Jennifer Doudna and Emanuelle Charpentier (AP Images)

Em­manuelle Char­p­en­tier and Jen­nifer Doud­na win the No­bel Prize for ground­break­ing CRISPR dis­cov­ery

Em­manuelle Char­p­en­tier and Jen­nifer Doud­na have won the No­bel Prize in chem­istry for their ground­break­ing work us­ing CRISPR/Cas9 in gene edit­ing.

Char­p­en­tier and Doud­na, now one of the busiest sci­en­tists/en­tre­pre­neurs in the Bay Area, birthed a whole new re­search field when they pub­lished their work on an eas­i­ly ac­ces­si­ble tech­nol­o­gy for gene edit­ing.

The break­through swift­ly in­spired hun­dreds of aca­d­e­m­ic stud­ies and spawned a wave of biotech star­tups like In­tel­lia, CRISPR Ther­a­peu­tics and oth­ers that sought to ap­ply the tech to the de­vel­op­ment of new ther­a­pies. And now those up­starts are be­ing fol­lowed by a whole new wave of com­pa­nies that are ap­ply­ing im­prove­ments on the duo’s foun­da­tion­al work.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.